Table 3.
Demographic and baseline characteristics of patients a.
| Characteristics | A Group (n = 28) | B Group (n = 31) | C Group (n = 31) | PLC Group (n = 32) | p |
|---|---|---|---|---|---|
| Male b | 20 (71.4%) | 18 (58.1%) | 18 (58.1%) | 21 (65.6%) | 0.660 |
| Age (year) c | 8.25 (2.78) | 8.74 (2.77) | 8.42 (2.55) | 8.56 (2.95) | 0.917 |
| Sneezing c | 1.69 (0.77) | 1.61 (0.67) | 1.49 (0.79) | 1.75 (0.64) | 0.527 |
| Rhinorrhea c | 1.83 (0.55) | 1.81 (0.68) | 1.69 (0.70) | 1.95 (0.60) | 0.435 |
| Nasal pruritus c | 1.73 (0.70) | 1.72 (0.53) | 1.69 (0.67) | 1.70 (0.79) | 0.997 |
| Nasal congestion c | 2.10 (0.63) | 1.97 (0.66) | 2.04 (0.71) | 2.04 (0.61) | 0.880 |
| TNSS c | 7.34 (1.44) | 7.11 (1.74) | 6.92 (1.57) | 7.44 (1.56) | 0.559 |
| Total serum IgE (kU/L) c | 652.58 (1366.19) | 547.66 (530.99) | 614.81 (661.08) | 405.68 (384.19) | 0.642 |
| Combine with asthma b | 11 (39.3%) | 14 (45.2%) | 11 (35.3%) | 12 (37.5%) | 0.878 |
| Combine with atopic dermatitis b | 12 (42.9%) | 11 (35.5%) | 8 (25.8%) | 11 (34.4%) | 0.590 |
| Combine with conjunctivitis b | 5 (17.9%) | 6 (19.4%) | 5 (16.1%) | 9 (28.1%) | 0.648 |
| Allergic sensitization b | |||||
| Mite (Df) | 23 (82.1%) | 25 (80.6%) | 20 (64.5%) | 25 (78.1%) | 0.350 |
| Mite (Dp) | 26 (92.9%) | 30 (96.8%) | 28 (90.3%) | 31 (96.9%) | 0.624 |
| Cockroach | 6 (21.4%) | 7 (22.6%) | 10 (32.3%) | 5 (15.6%) | 0.470 |
| Animal dander (Cats) | 6 (21.4%) | 4 (12.9%) | 7 (22.6%) | 7 (21.9%) | 0.749 |
| Animal dander (Dogs) | 7 (25.0%) | 6 (19.4%) | 7 (22.6%) | 9 (28.1%) | 0.869 |
| Mold | 1 (3.6%) | 2 (6.5%) | 2 (6.5%) | 1 (3.1%) | 0.887 |
a Severity of each symptom was measured on a 4-point scale: 0 = absent; 1 = mild; 2 = moderate; 3 = severe. Scores for each symptom were added to obtain the TNSS. b Data are presented as n (%). c Data are presented as mean (standard deviation).